Osteopore's Breakthrough Natural Tissue Regeneration Technology Leaps into Global Spotlight
The global leader's innovative regenerative medical technology and devices
vastly improve patient outcomes and reduce overall medical costs.
SINGAPORE, Nov. 8, 2022 /PRNewswire/ -- Osteopore International
Regrowing Damaged Body Parts: How Osteopore, an Australian-listed Company, is Making it Accessible
SINGAPORE, Nov. 9, 2021 /PRNewswire/ -- Osteopore, an Australian and Singapore based leader in regenerative implants on a commercial scale, is developing technology that enables widespread adoption of tissue engineering. Despite the global average life expectancy rising by more than 6 years betwe...
Cooperation Agreement with Terumo Blood And Cell Technologies to Promote and Sell Osteopore Products
Highlights: * Cooperation Agreement with Terumo Blood and Cell Technologies to promote and sell both companies complementary regenerative products inAsia-Pacific. * Terumo Blood and Cell Technologies' products will be used to concentrate a patient's bone marrow and mixed into Osteopore scaffo...
World's First 3D Regenerative Implant and Regenerative Surgical Technique To Regrow Man's Skull
SINGAPORE, Aug. 3, 2020 /PRNewswire/ -- Osteopore International Pte Ltd, a Singapore-headquartered company leading the way in regenerative bone implants, is proud to announce the success of its technology in a new medical procedure that took place inBrisbane, Australia, in December last year. Pio...
